Traditional methods could only qualitatively detect the presence of the Y chromosome, failing to distinguish between male-male twins and male-female twins. They also lacked the capability to identify residual male cfDNA after fetal reduction procedures. Zentrogene’s NGS-based technology achieves three breakthroughs:
As a pioneer in Hong Kong’s genetic testing field, Zentrogene has established a global technology matrix covering pre-pregnancy, prenatal, and oncology applications through its integrated Sanger sequencing and NGS platforms. This NGS breakthrough underscores its ‘Technology-Driven Globalization’ strategy, leveraging Hong Kong’s expertise to deliver precision medical solutions worldwide. Zentrogene continues to advance genetic technology, safeguarding every family’s hopes with scientific rigor.
For details, visit:
https://www.zentrogene.com/
https://www.zentrogene.com.hk/
Official Cooperation Contacts:
Telephone: +86 18051865085 (WeChat same number)
Telegram: +855 99990026
Facebook: Zentrogene
Hashtag: #Zentrogene
The issuer is solely responsible for the content of this announcement.
Reinforcing Thailand’s position as a trusted, high-quality destination through emotion-driven storytellingBANGKOK, THAILAND - Media OutReach…
SINGAPORE - Media OutReach Newswire - 30 January 2026 - Digital transformation has become an…
HONG KONG SAR - Media OutReach Newswire - 30 January 2026 - On January 27,…
HONG KONG SAR - Media OutReach Newswire - 30 January 2026 - Madame Tussauds Hong…
BANGKOK, THAILAND - Media OutReach Newswire - 30 January 2026 - Amid heightened volatility across…
CHONGLI, CHINA - Media OutReach Newswire - 30 January 2026 - The "2026 Chongli Forum"…